drugset / Trial / NCT00752830

To Evaluate the Effect of Food on the Pharmacokinetics (PK) of AZD0328

NCT00752830 ↗

Phase 1 Completed 14 enrolled AstraZeneca
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate the effect of food on the pharmacokinetics of AZD0328 in healthy male volunteers. AZD0328 will be administered as a single oral dose (capsule) during two treatment periods, after food intake or during fasting condition.

Timeline

Start
2008-09
Primary completion
2008-10
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD0328 Small molecule — Oral

Indications

No indication recorded.